The following medical description of a pancreas is provided. This is a medical observation from a doctor. The doctor notes one or multiple cysts and their dimensions. From the potentially multiple size values, the doctor is looking for the largest dimension of any of the cyst observations which is called the dominant cyst size. 

    ***Examples: 
    Pancreas: 'There is again noted to be markedly atrophic with fatty replacement, similar to prior study. There is possibly a cystic lesion in the tail the pancreas that measures up to 2.2 cm and possibly, a second adjacent cystic lesion that measures approximately 1.4 cm. These appear similar to prior study. They possibly represent pseudocysts although other cystic lesions of the pancreas do not be excluded. It is also conceivable be simply represent fluid filled small bowel loops although it would be somewhat unusual for them to have the same appearance over multiple studies. 
    Dominant Cyst Size: 2.2 cm

    Pancreas: 'Numerous pancreatic cystic lesions are redemonstrated measuring up to 2.1 cm. These are nonspecific and may represent sequela of prior pancreatitis or sidebranch IPMNs. These can be reassessed with MRI in one year.'
    Dominant Cyst Size: 2.1cm

    Pancreas: 'Pancreas: Pancreas appear atrophic. Hypodense lesion seen in the uncinate process of the pancreas (series 6 images 519) measuring 1.6 x 2.3 cm previously measuring 2.4 x 1.0 cm. Another well-defined cystic attenuation lesion seen in the body of the pancreas extending inferiorly measuring 1.6 x 2.1 cm and tail of the pancreas measuring 1.2 x 1.6 cm not well appreciated on prior scan due to movement artifact measuring approximately 1.5 cm on 9/7/2021.'

    Dominant Cyst Size: 2.4 cm

    Pancreas: 'Pancreas: A 3 cm x 2.7 cm pancreatic tail cystic lesion has increased in size from prior (previously 2.4 cm x 1.9 cm). An approximately 1 cm pancreatic neck cyst, now measures about 3.1 cm cyst associated centimeters previously along the maximum transverse dimension. Remainder of the pancreas is unchanged.'
    Dominant Cyst Size: 3.1 cm

    Pancreas: 'PANCREAS: Evaluation of the pancreatic cystic lesions is limited by CT technique. Although the largest lesion in the body of the pancreas is stable, measuring up to 14 mm. No pancreatic ductal dilatation. No findings of acute pancreatitis.'
    Dominant Cyst Size : 14 mm
    
    ***Input
    Pancreas: 
FINDINGS: Left lower lobe pulmonary nodule would be better evaluated on the CT chest concurrently performed.
 
A 4.5 cm complex cystic lesion within the pancreatic uncinate process is unchanged from prior. Numerous additional cystic lesions throughout the pancreatic body/tail and significant pancreatic ductal dilatation is also unchanged. 
 
On image 40 series 12 there is infiltrating soft tissue about the pancreatic head and mesenteric root again involving the SMA, celiac axis, common hepatic artery and splenic artery with similar near complete occlusion of the portal vein just prior to the portal splenic confluence. Nonocclusive thrombus is again noted in the SMV (image 61 series 14). Peripancreatic and upper abdominal lymphadenopathy are stable from prior. Small amount of abdominal ascites is again noted. There is a stable 3.4 cm infrarenal abdominal aortic aneurysm. Trace right pleural effusion and left lung nodule are noted.
 
There is similar focal fat in the gallbladder fossa. No enhancing liver lesions are identified. There is no biliary ductal dilatation.The spleen, adrenal glands, and kidneys are unremarkable except for bilateral simple and hemorrhagic cysts.
 
There is an infrarenal abdominal aortic aneurysm measuring 3.2 cm, possibly with a small dissection flap, unchanged.
 MRI ABDOMEN W WO IV CONTRAST(BH GH YH YHC LM) on 10/12/2019 11:37 AM
 
INDICATION: Evaluate treatment response. Patient with history of pancreatic, lung, bladder, and prostate malignancy.
 
COMPARISON: MRI abdomen August 1, 2019.
 
TECHNIQUE: Multiplanar multisequence MR of the abdomen was performed with and without contrast. A total of 12 ml Dotarem was administered intravenously. Subtractions images are provided.
 
FINDINGS: Left lower lobe pulmonary nodule would be better evaluated on the CT chest concurrently performed.
 
A 4.5 cm complex cystic lesion within the pancreatic uncinate process is unchanged from prior. Numerous additional cystic lesions throughout the pancreatic body/tail and significant pancreatic ductal dilatation is also unchanged. 
 
On image 40 series 12 there is infiltrating soft tissue about the pancreatic head and mesenteric root again involving the SMA, celiac axis, common hepatic artery and splenic artery with similar near complete occlusion of the portal vein just prior to the portal splenic confluence. Nonocclusive thrombus is again noted in the SMV (image 61 series 14). Peripancreatic and upper abdominal lymphadenopathy are stable from prior. Small amount of abdominal ascites is again noted. There is a stable 3.4 cm infrarenal abdominal aortic aneurysm. Trace right pleural effusion and left lung nodule are noted.
 
There is similar focal fat in the gallbladder fossa. No enhancing liver lesions are identified. There is no biliary ductal dilatation.The spleen, adrenal glands, and kidneys are unremarkable except for bilateral simple and hemorrhagic cysts.
 
There is an infrarenal abdominal aortic aneurysm measuring 3.2 cm, possibly with a small dissection flap, unchanged.
MRI ABDOMEN W WO IV CONTRAST(BH GH YH YHC LM) on 10/12/2019 11:37 AM
 
INDICATION: Evaluate treatment response. Patient with history of pancreatic, lung, bladder, and prostate malignancy.
 
COMPARISON: MRI abdomen August 1, 2019.
 
TECHNIQUE: Multiplanar multisequence MR of the abdomen was performed with and without contrast. A total of 12 ml Dotarem was administered intravenously. Subtractions images are provided.
 
FINDINGS: Left lower lobe pulmonary nodule would be better evaluated on the CT chest concurrently performed.
 
A 4.5 cm complex cystic lesion within the pancreatic uncinate process is unchanged from prior. Numerous additional cystic lesions throughout the pancreatic body/tail and significant pancreatic ductal dilatation is also unchanged. 
 
On image 40 series 12 there is infiltrating soft tissue about the pancreatic head and mesenteric root again involving the SMA, celiac axis, common hepatic artery and splenic artery with similar near complete occlusion of the portal vein just prior to the portal splenic confluence. Nonocclusive thrombus is again noted in the SMV (image 61 series 14). Peripancreatic and upper abdominal lymphadenopathy are stable from prior. Small amount of abdominal ascites is again noted. There is a stable 3.4 cm infrarenal abdominal aortic aneurysm. Trace right pleural effusion and left lung nodule are noted.
 
There is similar focal fat in the gallbladder fossa. No enhancing liver lesions are identified. There is no biliary ductal dilatation.The spleen, adrenal glands, and kidneys are unremarkable except for bilateral simple and hemorrhagic cysts.
 
There is an infrarenal abdominal aortic aneurysm measuring 3.2 cm, possibly with a small dissection flap, unchanged.
 MRI ABDOMEN W WO IV CONTRAST(BH GH YH YHC LM) on 10/12/2019 11:37 AM
 
INDICATION: Evaluate treatment response. Patient with history of pancreatic, lung, bladder, and prostate malignancy.
 
COMPARISON: MRI abdomen August 1, 2019.
 
TECHNIQUE: Multiplanar multisequence MR of the abdomen was performed with and without contrast. A total of 12 ml Dotarem was administered intravenously. Subtractions images are provided.
 
FINDINGS: Left lower lobe pulmonary nodule would be better evaluated on the CT chest concurrently performed.
 
A 4.5 cm complex cystic lesion within the pancreatic uncinate process is unchanged from prior. Numerous additional cystic lesions throughout the pancreatic body/tail and significant pancreatic ductal dilatation is also unchanged. 
 
On image 40 series 12 there is infiltrating soft tissue about the pancreatic head and mesenteric root again involving the SMA, celiac axis, common hepatic artery and splenic artery with similar near complete occlusion of the portal vein just prior to the portal splenic confluence. Nonocclusive thrombus is again noted in the SMV (image 61 series 14). Peripancreatic and upper abdominal lymphadenopathy are stable from prior. Small amount of abdominal ascites is again noted. There is a stable 3.4 cm infrarenal abdominal aortic aneurysm. Trace right pleural effusion and left lung nodule are noted.
 
There is similar focal fat in the gallbladder fossa. No enhancing liver lesions are identified. There is no biliary ductal dilatation.The spleen, adrenal glands, and kidneys are unremarkable except for bilateral simple and hemorrhagic cysts.
 
There is an infrarenal abdominal aortic aneurysm measuring 3.2 cm, possibly with a small dissection flap, unchanged.
    Output: 
    